Double-Punch cancer trial: radiation and immune drugs team up
NCT ID NCT04454489
Summary
This study tested whether combining a short, intense course of radiation with an immunotherapy drug could help control advanced head and neck cancer. It involved 21 adults whose cancer had returned or spread and was no longer curable with standard surgery or radiation. The goal was to see if this combination could shrink tumors, slow the cancer's growth, and be tolerated by patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.